195 related articles for article (PubMed ID: 2163560)
1. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses.
Bürki F; Rossmanith W; Nowotny N; Pallan C; Möstl K; Lussy H
Vet Q; 1990 Apr; 12(2):80-6. PubMed ID: 2163560
[TBL] [Abstract][Full Text] [Related]
2. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus.
Burrows R; Goodridge D; Denyer MS
Vet Rec; 1984 Apr; 114(15):369-74. PubMed ID: 6328728
[TBL] [Abstract][Full Text] [Related]
3. Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines.
Bresgen C; Lämmer M; Wagner B; Osterrieder N; Damiani AM
Vet Microbiol; 2012 Nov; 160(1-2):9-16. PubMed ID: 22633483
[TBL] [Abstract][Full Text] [Related]
4. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
Bryans JT; Allen GP
Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
[TBL] [Abstract][Full Text] [Related]
5. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.
Heldens JG; Hannant D; Cullinane AA; Prendergast MJ; Mumford JA; Nelly M; Kydd JH; Weststrate MW; van den Hoven R
Vaccine; 2001 Jul; 19(30):4307-17. PubMed ID: 11457558
[TBL] [Abstract][Full Text] [Related]
6. Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.
Patel JR; Bateman H; Williams J; Didlick S
Vet Microbiol; 2003 Jan; 91(1):23-39. PubMed ID: 12441229
[TBL] [Abstract][Full Text] [Related]
7. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
Kydd JH; Wattrang E; Hannant D
Vet Immunol Immunopathol; 2003 Dec; 96(3-4):207-17. PubMed ID: 14592733
[TBL] [Abstract][Full Text] [Related]
8. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
[TBL] [Abstract][Full Text] [Related]
10. Vaccination of mares against equine herpesvirus-1.
Pickles AC
Vet Rec; 1992 Feb; 130(8):167-8. PubMed ID: 1314446
[No Abstract] [Full Text] [Related]
11. [Preventative vaccination against EHV (equine herpesvirus) abortion].
Becker W
Tierarztl Prax; 1988; 16(1):61-3. PubMed ID: 2835828
[TBL] [Abstract][Full Text] [Related]
12. Equine herpesvirus.
Vet Rec; 1989 May; 124(19):519. PubMed ID: 2547266
[No Abstract] [Full Text] [Related]
13. Towards a vaccine against equine herpesvirus 1.
Sabine M; Whalley JM
Aust Vet J; 1989 Dec; 66(12):403-4. PubMed ID: 2559691
[No Abstract] [Full Text] [Related]
14. Vaccines for EHV1 abortion.
Mitchell D
Vet Rec; 1983 Mar; 112(12):285. PubMed ID: 6302971
[No Abstract] [Full Text] [Related]
15. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture.
Eaglesome MD; Henry JN; McKnight JD
Can Vet J; 1979 May; 20(5):145-7. PubMed ID: 226261
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHΔgM) confers partial protection against infection.
Kydd JH; Hannant D; Robinson RS; Bryant N; Osterrieder N
Vaccine; 2020 Jan; 38(2):388-398. PubMed ID: 31629571
[TBL] [Abstract][Full Text] [Related]
17. Attempts to immunoprotect adult horses, specifically pregnant mares, with commercial vaccines against clinical disease induced by equine herpesvirus-1.
Bürki F; Nowotny N; Oulehla J; Schmehlik O; Möstl K; Pallan C; Rossmanith E
Zentralbl Veterinarmed B; 1991 Aug; 38(6):432-40. PubMed ID: 1659067
[TBL] [Abstract][Full Text] [Related]
18. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.
Mumford JA; Bates J
Vet Rec; 1984 Apr; 114(15):375-81. PubMed ID: 6328729
[TBL] [Abstract][Full Text] [Related]
19. [Year-round antibody profile of groups of horses of a herd kept in isolation after differently terminating use of an experimental viral combination vaccine].
Bürki F; Nowotny N; Hofer A
Dtsch Tierarztl Wochenschr; 1991 Mar; 98(3):82-9. PubMed ID: 1646100
[TBL] [Abstract][Full Text] [Related]
20. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.
Schnabel CL; Babasyan S; Rollins A; Freer H; Wimer CL; Perkins GA; Raza F; Osterrieder N; Wagner B
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
